Aptevo Therapeutics Inc [NASDAQ: APVO] surged by $0.07 during the normal trading session on while it closed the day at $0.38.
Aptevo Therapeutics Inc stock has also gained 15.15% of its value over the past 7 days. However, APVO stock has declined by -88.86% in the 3 months of the year. Over the past six months meanwhile, it has lost -95.13% and lost -91.18% year-on date.
The market cap for APVO stock reached $3.08 million, with 8.11 million shares outstanding and 7.85 million shares in the current float. Compared to the average trading volume of 3.09M shares, APVO reached a trading volume of 118501101 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Aptevo Therapeutics Inc [APVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APVO shares is $21.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APVO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Aptevo Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2018. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on October 05, 2017, representing the official price target for Aptevo Therapeutics Inc stock.
APVO stock trade performance evaluation
Aptevo Therapeutics Inc [APVO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.15. With this latest performance, APVO shares dropped by -45.20% in over the last four-week period, additionally sinking by -95.13% over the last 6 months – not to mention a drop of -98.72% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APVO stock in for the last two-week period is set at 31.05, with the RSI for the last a single of trading hit 37.26, and the three-weeks RSI is set at 30.77 for Aptevo Therapeutics Inc [APVO]. The present Moving Average for the last 50 days of trading for this stock 1.1015, while it was recorded at 0.3300 for the last single week of trading, and 6.1619 for the last 200 days.
Aptevo Therapeutics Inc [APVO]: An insightful look at the core fundamentals
Aptevo Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.67 and a Current Ratio set at 0.67.
Earnings per share (EPS) analysis for Aptevo Therapeutics Inc [APVO] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APVO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Aptevo Therapeutics Inc go to 51.40%.
